268 related articles for article (PubMed ID: 35459935)
1. Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity.
Yao H; Liu M; Wang L; Zu Y; Wu C; Li C; Zhang R; Lu H; Li F; Xi S; Chen S; Gu X; Liu T; Cai J; Wang S; Yang M; Xing GG; Xiong W; Hua L; Tang Y; Wang G
Cell Res; 2022 Jun; 32(6):570-584. PubMed ID: 35459935
[TBL] [Abstract][Full Text] [Related]
2. Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy.
Wang L; Liu M; Zu Y; Yao H; Wu C; Zhang R; Ma W; Lu H; Xi S; Liu Y; Hua L; Wang G; Tang Y
Eur J Med Chem; 2022 Jun; 236():114260. PubMed ID: 35385807
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs).
Shen Z; Ratia K; Krider I; Ackerman-Berrier M; Penton C; Musku SR; Gordon-Blake JM; Laham MS; Christie N; Ma N; Fu J; Xiong R; Courey JM; Velma GR; Thatcher GRJ
J Med Chem; 2023 Dec; 66(24):16704-16727. PubMed ID: 38096366
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD
Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ
Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631
[TBL] [Abstract][Full Text] [Related]
5. Discovery of DS68702229 as a Potent, Orally Available NAMPT (Nicotinamide Phosphoribosyltransferase) Activator.
Akiu M; Tsuji T; Iida K; Sogawa Y; Terayama K; Yokoyama M; Tanaka J; Asano D; Honda T; Sakurai K; Pinkerton AB; Nakamura T
Chem Pharm Bull (Tokyo); 2021; 69(11):1110-1122. PubMed ID: 34719594
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK
Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a Potent Nicotinamide Phosphoribosyltransferase Activator for Improving Aging-associated Dysfunctions.
Yang S; Sun D; Wu Y; Chen S; Guo Y; Li J; Dong G; Sheng C
J Med Chem; 2024 Mar; 67(5):4120-4130. PubMed ID: 38367219
[TBL] [Abstract][Full Text] [Related]
8. P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage.
Wang G; Han T; Nijhawan D; Theodoropoulos P; Naidoo J; Yadavalli S; Mirzaei H; Pieper AA; Ready JM; McKnight SL
Cell; 2014 Sep; 158(6):1324-1334. PubMed ID: 25215490
[TBL] [Abstract][Full Text] [Related]
9. Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators.
Pinkerton AB; Sessions EH; Hershberger P; Maloney PR; Peddibhotla S; Hopf M; Sergienko E; Ma CT; Smith LH; Jackson MR; Tanaka J; Tsuji T; Akiu M; Cohen SE; Nakamura T; Gardell SJ
Bioorg Med Chem Lett; 2021 Jun; 41():128007. PubMed ID: 33798699
[TBL] [Abstract][Full Text] [Related]
10. Targeting NAMPT as a therapeutic strategy against stroke.
Wang SN; Miao CY
Stroke Vasc Neurol; 2019 Jul; 4(2):83-89. PubMed ID: 31338216
[TBL] [Abstract][Full Text] [Related]
11. Both gain and loss of Nampt function promote pressure overload-induced heart failure.
Byun J; Oka SI; Imai N; Huang CY; Ralda G; Zhai P; Ikeda Y; Ikeda S; Sadoshima J
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H711-H725. PubMed ID: 31347918
[TBL] [Abstract][Full Text] [Related]
12. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.
Velma GR; Krider IS; Alves ETM; Courey JM; Laham MS; Thatcher GRJ
J Med Chem; 2024 Apr; 67(8):5999-6026. PubMed ID: 38580317
[TBL] [Abstract][Full Text] [Related]
13. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives.
Wen F; Gui G; Wang X; Ye L; Qin A; Zhou C; Zha X
Bioorg Med Chem; 2024 Feb; 99():117595. PubMed ID: 38244254
[TBL] [Abstract][Full Text] [Related]
14. Targeting Nicotinamide Phosphoribosyltransferase as a Potential Therapeutic Strategy to Restore Adult Neurogenesis.
Wang SN; Xu TY; Li WL; Miao CY
CNS Neurosci Ther; 2016 Jun; 22(6):431-9. PubMed ID: 27018006
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide Phosphoribosyltransferase as a Key Molecule of the Aging/Senescence Process.
Khaidizar FD; Bessho Y; Nakahata Y
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918226
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy.
LoCoco PM; Risinger AL; Smith HR; Chavera TS; Berg KA; Clarke WP
Elife; 2017 Nov; 6():. PubMed ID: 29125463
[TBL] [Abstract][Full Text] [Related]
17. NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.
Xiong X; Yu J; Fan R; Zhang C; Xu L; Sun X; Huang Y; Wang Q; Ruan HB; Qian X
PLoS One; 2019; 14(2):e0212523. PubMed ID: 30794635
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway.
Feng D; Xu D; Murakoshi N; Tajiri K; Qin R; Yonebayashi S; Okabe Y; Li S; Yuan Z; Aonuma K; Ieda M
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629939
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities.
Chen H; Wang S; Zhang H; Nice EC; Huang C
Expert Rev Anticancer Ther; 2016 Aug; 16(8):827-38. PubMed ID: 27186719
[TBL] [Abstract][Full Text] [Related]
20. Novel carbon skeletons activate human NicotinAMide Phosphoribosyl Transferase (NAMPT) enzyme in biochemical assay.
Almeida KH; Avalos-Irving L; Berardinelli S; Chauvin K; Yanez S
PLoS One; 2023; 18(3):e0283428. PubMed ID: 36996070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]